From gene to disease; HFE mutations in primary haemochromatosis;Van gen naar ziekte; HFE-mutaties bij primaire hemochromatose

Nederlands Tijdschrift voor Geneeskunde

Volumn 147, Issue 14, 2003, Pages 652-656

  Swinkels, D W ^a   Jacobs, E M G ^a  

^a RADBOUD UNIVERSITY MEDICAL CENTER   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

CARRIER PROTEIN; CYSTEINE; HFE PROTEIN; IRON; MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 1; TYROSINE;

AMINO ACID SUBSTITUTION; ARTICLE; AUTOSOMAL RECESSIVE DISORDER; CRYPT CELL; EUROPE; GENE MUTATION; HEMOCHROMATOSIS; HETEROZYGOSITY; HOMOZYGOSITY; HUMAN; INTESTINE VILLUS; IRON ABSORPTION; IRON INTAKE; IRON OVERLOAD; LIVER BIOPSY; MAJOR HISTOCOMPATIBILITY COMPLEX; MISSENSE MUTATION; MULTIPLE ORGAN FAILURE; PREVALENCE; PROTEIN DOMAIN;

AMINO ACID SUBSTITUTION; CYSTEINE; GENOTYPE; HEMOCHROMATOSIS; HISTOCOMPATIBILITY ANTIGENS CLASS I; HUMANS; MEMBRANE PROTEINS; MUTATION, MISSENSE; TYROSINE;

EID: 0037420524     PISSN: 00282162     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (13)

1. Swinkels DW, Marx JJM. Diagnostiek en behandeling van primaire hemochromatose. Ned Tijdschr Geneeskd 1999;143:1404-8.
2. Adams P, Brissot P, Powell LW. EASL International consensus conference on haemochromatosis. J Hepatol 2000;33:485-504.
3. Lieu PT, Heiskala M, Peterson PA, Yang Y. The roles of iron in health and disease. Mol Aspects Med 2001;22:1-87.
4. Feder JN, Gnirke A, Thomas W, Tsuchihashi Z, Ruddy DA, Basava A, et al. A novel MHC class I-like gene is mutated in patients with hereditary haemochromatosis. Nat Genet 1996;13:399-408.
5. Lyon E, Frank EL. Hereditary hemochromatosis since discovery of the HFE gene. Clin Chem 2001;47:1147-56.
6. Camaschella C, Roetto A, Cali A, De Gobbi M, Garozzo G, Majorano N, et al. The gene TFR2 is mutated in a new type of haemochromatosis mapping to 7q22. Nat Genet 2000;25:14-5.
7. Njajou OT, Vaessen N, Joosse M, Berghuis B, Dongen JWF van, Breuning MH, et al. A mutation in SLC11A3 is associated with autosomal dominant hemochromatosis. Nat Genet 2001;28:213-4.
8. Townsend A, Drakesmith H. Role of HFE in iron metabolism, hereditary haemochromatosis, anaemia of chronic disease, and secondary iron overload. Lancet 2002;359:786-90.
9. Andrews NC. Disorders of iron metabolism. N Engl J Med 1999;341:1986-95.
10. Bradley LA, Haddow JE, Palomaki GE, Population screening for haemochromatosis: a unifying analysis of published intervention trials. J Med Screen 1996;3:178-84.
11. Olynyk JK, Cullen DJ, Aquilia S, Rossi E, Summerville L, Powell LW. A population -based study of the clinical expression of the hemochromatosis gene. N Engl J Med 1999;341:718-24.
12. Beutler E, Felitti VJ, Koziol JA, Ho NJ, Gelbart T. Penetrance of 845G → A (C282Y) HFE hereditary haemochromatosis mutation in the USA. Lancet 2002;359:211-8.
13. Bulaj ZJ, Ajioka RS, Phillips JD, LaSalle BA, Jorde LB, Griffen LM, et al. Disease-related conditions in relatives of patients with hemochromatosis. N Engl J Med 2000;343:1529-35.